JPS6197274A - 中枢神経系に作用するチアジアゾール誘導体、その製造方法及びこの薬理上許容し得る塩 - Google Patents

中枢神経系に作用するチアジアゾール誘導体、その製造方法及びこの薬理上許容し得る塩

Info

Publication number
JPS6197274A
JPS6197274A JP60228991A JP22899185A JPS6197274A JP S6197274 A JPS6197274 A JP S6197274A JP 60228991 A JP60228991 A JP 60228991A JP 22899185 A JP22899185 A JP 22899185A JP S6197274 A JPS6197274 A JP S6197274A
Authority
JP
Japan
Prior art keywords
thiadiazole
formula
group
amine
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60228991A
Other languages
English (en)
Japanese (ja)
Inventor
カミーユ・ジヨルジユ・ウエルムート
ロジエ・ブロダン
ポール・ウオルム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPS6197274A publication Critical patent/JPS6197274A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP60228991A 1984-10-18 1985-10-16 中枢神経系に作用するチアジアゾール誘導体、その製造方法及びこの薬理上許容し得る塩 Pending JPS6197274A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8415991 1984-10-18
FR8415991A FR2572074B1 (fr) 1984-10-18 1984-10-18 Derives du thiadiazole actifs sur le systeme nerveux central, procede d'obtention et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
JPS6197274A true JPS6197274A (ja) 1986-05-15

Family

ID=9308790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60228991A Pending JPS6197274A (ja) 1984-10-18 1985-10-16 中枢神経系に作用するチアジアゾール誘導体、その製造方法及びこの薬理上許容し得る塩

Country Status (16)

Country Link
US (1) US4596802A (en, 2012)
EP (1) EP0183577B1 (en, 2012)
JP (1) JPS6197274A (en, 2012)
KR (1) KR860003245A (en, 2012)
AT (1) ATE50253T1 (en, 2012)
AU (1) AU577159B2 (en, 2012)
CA (1) CA1259990A (en, 2012)
DE (1) DE3575923D1 (en, 2012)
DK (1) DK469285A (en, 2012)
ES (1) ES8605269A1 (en, 2012)
FR (1) FR2572074B1 (en, 2012)
GR (1) GR852530B (en, 2012)
IL (1) IL76652A0 (en, 2012)
NZ (1) NZ213865A (en, 2012)
PT (1) PT81314B (en, 2012)
ZA (1) ZA858030B (en, 2012)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625774D0 (en) * 1986-10-28 1986-12-03 Reckitt & Colmann Prod Ltd Thiadiazole derivative
FR2636628B1 (fr) * 1988-08-25 1990-12-28 Sanofi Sa Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
IT1255219B (it) * 1992-07-14 1995-10-20 Ct Lab Farm Srl Derivati del tiadiazolo per la cura degli stati depressivi
KR20070073791A (ko) * 2004-10-18 2007-07-10 암젠 인코포레이티드 티아디아졸 화합물 및 이의 사용방법
US7919504B2 (en) * 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053085A (en, 2012) * 1964-03-26
FR2092714B1 (en, 2012) * 1970-06-11 1974-03-22 Melle Bezons
US3919428A (en) * 1972-01-17 1975-11-11 Sandoz Ag 2-Amino-5-(substituted or unsubstituted phenylalkyl)1,3,4-thiadiazoles for treating anxiety

Also Published As

Publication number Publication date
DK469285A (da) 1986-04-19
FR2572074B1 (fr) 1987-07-17
DK469285D0 (da) 1985-10-14
US4596802A (en) 1986-06-24
FR2572074A1 (fr) 1986-04-25
ATE50253T1 (de) 1990-02-15
KR860003245A (ko) 1986-05-21
ES8605269A1 (es) 1986-03-16
AU4848085A (en) 1986-04-24
IL76652A0 (en) 1986-02-28
CA1259990A (en) 1989-09-26
PT81314B (pt) 1987-11-30
GR852530B (en, 2012) 1986-02-19
ES547962A0 (es) 1986-03-16
AU577159B2 (en) 1988-09-15
NZ213865A (en) 1988-05-30
PT81314A (fr) 1985-11-01
DE3575923D1 (de) 1990-03-15
EP0183577B1 (fr) 1990-02-07
EP0183577A1 (fr) 1986-06-04
ZA858030B (en) 1986-06-25

Similar Documents

Publication Publication Date Title
EP0047536B1 (en) Substituted propylamines
US3641152A (en) 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines
FR2673182A1 (fr) Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique.
CS229940B2 (en) Production method substiuted pyridazine derivatives
IE44904B1 (en) Aminophosphonous acids and processes for their preparation
EP0092458A2 (fr) Dérives d'imidazo(1,2-a)pyridine, leur préparation et leur application en thérapeutique
CS239929B2 (en) Processing of pyridazine derivatives
JPS6197274A (ja) 中枢神経系に作用するチアジアゾール誘導体、その製造方法及びこの薬理上許容し得る塩
BRPI0810192B1 (pt) aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diaza-espiro [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo.
FR2597478A1 (fr) Benzimidazoles et imidazopyridines sulfonamides, leur preparation et leur application en tant que medicaments.
EP0063084B1 (fr) Dérivés de phénéthanolamine, leur préparation et leur application en thérapeutique
FR2460294A1 (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
US3879531A (en) 2-aminothiazoles compositions and methods for using them as psychotherapeutic agents
EP0008259A1 (fr) Nouveaux dérivés de la pipéridylbenzimidazolinone, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0079810A1 (fr) Nouveaux dérivés de la phényl-4 quinazoline actifs sur le système nerveux central
FR2464259A1 (fr) Nouvelles 5-(2-chlorophenyl)-6h-1,3,4-thiadiazine-2-amines, utiles notamment comme anticonvulsivants, et leur procede de preparation
JPH06511259A (ja) 治療用アミン
EP0005091B1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
HU190710B (en) Process for preparing 2-/4-piperazinyl/-4-phenyl-quinazoline derivatives
FR2559771A1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
IE50228B1 (en) Nitrosourea derivatives,process for preparing them,and pharmaceutical compositions containing them
HU178147B (en) Process for producing hexahydro-1,4-oxazepines
CH629194A5 (fr) Amino aryl triazines-1,2,4 utilisables dans le traitement d'algies diverses.
CH641775A5 (fr) N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment.
US3975433A (en) 1-(2,4-Dimethoxy-phenyl)-3-(2-hydroxyethyl)thiourea